Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy STRATA Skin Sciences stock

Own STRATA Skin Sciences stock in just a few minutes.

STRATA Skin Sciences, Inc is a medical devices business based in the US. STRATA Skin Sciences shares (SSKN) are listed on the NASDAQ and all prices are listed in US Dollars. STRATA Skin Sciences employs 109 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in STRATA Skin Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SSKN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

STRATA Skin Sciences share price

Use our graph to track the performance of SSKN stocks over time.

STRATA Skin Sciences shares at a glance

Information last updated 2021-04-23.
52-week range$1.00 - $2.84
50-day moving average $1.73
200-day moving average $1.64
Wall St. target price$4.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.24

Buy STRATA Skin Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy STRATA Skin Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is STRATA Skin Sciences under- or over-valued?

Valuing STRATA Skin Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STRATA Skin Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

STRATA Skin Sciences's EBITDA

STRATA Skin Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $78,000.

The EBITDA is a measure of a STRATA Skin Sciences's overall financial performance and is widely used to measure a its profitability.

STRATA Skin Sciences financials

Revenue TTM $23.1 million
Gross profit TTM $14.1 million
Return on assets TTM -5.41%
Return on equity TTM -16.18%
Profit margin -19.11%
Book value $0.77
Market capitalisation $59.2 million

TTM: trailing 12 months

Shorting STRATA Skin Sciences shares

There are currently 337,136 STRATA Skin Sciences shares held short by investors – that's known as STRATA Skin Sciences's "short interest". This figure is 197.1% up from 113,460 last month.

There are a few different ways that this level of interest in shorting STRATA Skin Sciences shares can be evaluated.

STRATA Skin Sciences's "short interest ratio" (SIR)

STRATA Skin Sciences's "short interest ratio" (SIR) is the quantity of STRATA Skin Sciences shares currently shorted divided by the average quantity of STRATA Skin Sciences shares traded daily (recently around 1.5 million). STRATA Skin Sciences's SIR currently stands at 0.23. In other words for every 100,000 STRATA Skin Sciences shares traded daily on the market, roughly 230 shares are currently held short.

However STRATA Skin Sciences's short interest can also be evaluated against the total number of STRATA Skin Sciences shares, or, against the total number of tradable STRATA Skin Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case STRATA Skin Sciences's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 STRATA Skin Sciences shares in existence, roughly 10 shares are currently held short) or 0.02% of the tradable shares (for every 100,000 tradable STRATA Skin Sciences shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against STRATA Skin Sciences.

Find out more about how you can short STRATA Skin Sciences stock.

STRATA Skin Sciences share dividends

We're not expecting STRATA Skin Sciences to pay a dividend over the next 12 months.

Have STRATA Skin Sciences's shares ever split?

STRATA Skin Sciences's shares were split on a 1:5 basis on 6 April 2017. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your STRATA Skin Sciences shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for STRATA Skin Sciences shares which in turn could have impacted STRATA Skin Sciences's share price.

STRATA Skin Sciences share price volatility

Over the last 12 months, STRATA Skin Sciences's shares have ranged in value from as little as $1 up to $2.84. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while STRATA Skin Sciences's is 2.5168. This would suggest that STRATA Skin Sciences's shares are significantly more volatile than the average for this exchange and represent a higher risk.

STRATA Skin Sciences overview

STRATA Skin Sciences, Inc. , a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of psoriasis, vitiligo, atopic dermatitis, eczema, and other skin disorders. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site